Abstract
There is growing evidence that implicates the epigenome in the development of bone and joint disorders. The complexity and dynamic nature of epigenetic regulations confound the investigation of these disorders. We will review current evidence that connects epigenetics to the development of autoimmune and musculoskeletal diseases. The pathogenesis of these disorders is likely to be related to modifications to epigenetics regulation by environmental signals in individuals with a certain genetic makeup. The epigenome is an attractive therapeutic target; however, successful epigenetic-based treatment will depend on a greater understanding of the molecular mechanisms controlling the epigenome and its alteration in rheumatic and bone disorders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
